SkyWater Technology Earnings Call Transcripts
Fiscal Year 2026
-
A $1.8B merger creates a vertically integrated US quantum platform, combining advanced quantum technology with secure, onshore semiconductor manufacturing. The deal accelerates product development, reduces costs, and strengthens US leadership in quantum infrastructure, while maintaining SkyWater's foundry model and customer protections.
-
The conference highlighted integrated U.S. foundry capabilities, expansion into quantum and advanced packaging, and a focus on critical infrastructure markets. Fab 25 boosts capacity and margin potential, while quantum and ATS businesses are set for continued growth. Profitability and $600M revenue are targeted for 2026.
Fiscal Year 2025
-
Record Q3 revenue and profitability were driven by strong contributions from Texas FAB25 and quantum computing, with four new quantum customers signed. Guidance for Q4 and 2026 is raised, reflecting continued momentum, though A&D revenue faces near-term headwinds from government funding delays.
-
ATS enables high-margin, customer-funded innovation, transitioning to volume wafer services and driving growth, especially in quantum technology. U.S. supply chain security and flexible manufacturing trends position the company as a key domestic foundry, with diversified revenue and strategic fab acquisitions.
-
Q2 revenue and margins exceeded guidance, driven by strong ATS performance. The Fab 25 acquisition is expected to double revenue and EBITDA, with significant growth in quantum computing and advanced packaging. Near-term margin compression is anticipated, but 2026 targets at $600M revenue and $60M EBITDA remain on track.
-
Q1 revenue and gross margin exceeded guidance, driven by new wafer services like ThermaView, while ATS was impacted by government budget delays. The pending Fab 25 acquisition and strong quantum segment growth support a positive outlook, with profitability expected in the second half.
-
The conference highlighted strong ATS-driven growth, customer-funded investments, and new platform launches, with a focus on reshoring and advanced packaging. Financials remain robust with stable debt, significant external funding, and a shift toward higher-margin, proprietary technologies.
Fiscal Year 2024
-
Q4 and full-year 2024 results exceeded expectations with record revenue and strong margins, driven by ATS growth in aerospace, defense, and quantum computing. The acquisition of Infineon's Fab 25 is set to double capacity, add $300 million in annual revenue, and immediately boost EBITDA and cash flow.
-
Record Q3 revenue and gross margin were driven by strong customer co-investment and operational efficiencies. Outlook for 2024 and 2025 remains positive, with growth expected in ATS and wafer services, and significant customer-funded tool investments planned.
-
ATS and customer-funded CapEx drive growth, with advanced packaging and biosensing as key opportunities. Margins are strong in core business, and long-term goals target $400M annual revenue and 40% gross margin. Unique U.S. foundry status supports leadership in defense, quantum, and medical chips.
-
Record Q2 revenue and first-ever non-GAAP positive EPS were driven by strong ATS and tool sales, with aerospace and defense as key growth areas. Customer-funded CapEx is ramping, and future growth is expected from biomedical and advanced packaging, despite ongoing softness in legacy wafer services.